A Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA From 2007–2013

Authors:

Abstract
The European Union and the United States have different legal frameworks in place for pediatric drug development, which can potentially lead to different p

This publication has 2 references indexed in Scilit: